Form 8-K - Current report:
SEC Accession No. 0000950170-24-084629
Filing Date
2024-07-18
Accepted
2024-07-18 17:00:10
Documents
11
Period of Report
2024-07-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K tbio-20240716.htm   iXBRL 8-K 45012
  Complete submission text file 0000950170-24-084629.txt   167732

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tbio-20240716.xsd EX-101.SCH 26957
14 EXTRACTED XBRL INSTANCE DOCUMENT tbio-20240716_htm.xml XML 5103
Mailing Address 10431 WATERIDGE CIRCLE SUITE 150 SAN DIEGO CA 92121
Business Address 10431 WATERIDGE CIRCLE SUITE 150 SAN DIEGO CA 92121 858-228-4115
Telesis Bio Inc. (Filer) CIK: 0001850079 (see all company filings)

EIN.: 451216839 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40497 | Film No.: 241125305
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)